Alpha-lipoic acid and neuropathy ALA may help reduce the symptoms of peripheral neuropathy, nerve damage that can be caused by diabetes
Understanding how it compares to alternatives helps you make informed decisions about which form suits your needs
Both are designed for patient self-administration and specifically engineered for subcutaneous delivery
Even when the injury is not severe enough to require surgery, recovery can be slow, especially when tendons, ligaments, fascia, and other connective tissues are involved
Conditions such as obesity and type 2 diabetes are major risk factors for MASH, prompting interest in treatments that can address multiple aspects of metabolic syndrome
Understanding the many factors that affect urine helps avoid wrong assumptions about side effects